April 21, 2024: Drawing Parallels Ozempic Lawsuit and Benicar MDL Settlement Analysis Some guidance in the Ozempic lawsuit might be gained from a review of the Benicar MDL
Once reconstituted, the rules change
19, the National Association of Attorneys General submitted a letter to acting FDA commissioner Sara Brenner, MD, MPH, asking the agency to take decisive action against bad actors unlawfully profiting off the high demand for FDA-approved weight loss and diabetes drugs. While states play a role in protecting their own consumers, many organizations that sell unsafe, unregulated versions of GLP-1 operate outside the country, the letter stated
Yet, because pantothenic acid is widely distributed in nature and deficiency is extremely rare in humans, most information regarding the consequences of deficiency has been gathered from experimental research in animals (reviewed in 4)
Br J Dermatol 167:5058